IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
33 hedge funds and large institutions have $2.43M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
33
Holders Change
+3
Holders Change %
+10%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
1
Calls
$2.22M
Puts
–
Net Calls
+$2.22M
Net Calls Change
-$3K